Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma

To assess the acute intraocular hypotensive efficacy of brimonidine tartrate 0.2% (a highly selective alpha2-adrenergic agonist) compared with dorzolamide 2% (a topical carbonic anhydrase inhibitor) as adjunct therapy to topical beta-blockers in patients with primary open-angle glaucoma. A randomize...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Graefe's archive for clinical and experimental ophthalmology 2000-04, Vol.238 (4), p.302-305
Hauptverfasser:	CENTOFANTI, M, MANNI, G, GREGORI, D, COCCO, F, LORENZANO, D, BUCCI, M. G
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic alpha-Agonists - administration & dosage Adrenergic alpha-Agonists - therapeutic use Adrenergic beta-Antagonists - administration & dosage Adrenergic beta-Antagonists - therapeutic use Aged Aged, 80 and over Biological and medical sciences Brimonidine Tartrate Carbonic Anhydrase Inhibitors - administration & dosage Carbonic Anhydrase Inhibitors - therapeutic use Cross-Over Studies Double-Blind Method Drug Therapy, Combination Eye Female Glaucoma Glaucoma, Open-Angle - drug therapy Humans Intraocular Pressure - drug effects Male Medical sciences Middle Aged Ophthalmic Solutions - administration & dosage Ophthalmic Solutions - therapeutic use Pharmacology. Drug treatments Quinoxalines - administration & dosage Quinoxalines - therapeutic use Sulfonamides - administration & dosage Sulfonamides - therapeutic use Thiophenes - administration & dosage Thiophenes - therapeutic use Tonometry, Ocular Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!